AMBRISENTAN

Generic: AMBRISENTAN

Apotex Corp.Manufacturer
ORALRoute
AMBRISENTANActive Substance
2022-05-19Original Approval

AMBRISENTAN is FDA application ANDA210701, sponsored by APOTEX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
9,293 reports
2
DEATH
7,241 reports
3
HEADACHE
5,866 reports
4
PNEUMONIA
4,408 reports
5
DIARRHOEA
4,145 reports
6
NAUSEA
3,494 reports
7
FATIGUE
3,418 reports
8
DIZZINESS
3,180 reports
9
MALAISE
2,671 reports
10
FLUID RETENTION
2,507 reports